Evidence map›Paper›PMID 38626267›Full record

ArticlePLoS pathogens2024

Evidence for vagal sensory neural involvement in influenza pathogenesis and disease.

Nathalie A J Verzele, Brendon Y Chua, Kirsty R Short, Aung Aung Kywe Moe, Isaac N Edwards, Helle Bielefeldt-Ohmann, Katina D Hulme, Ellesandra C Noye, Marcus Z W Tong, Patrick C Reading and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Nociceptor neurons shape antiviral immunity.Journal of neuroinflammation · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Nathalie A J VerzeleSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
Brendon Y ChuaThe Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia.
Kirsty R ShortSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
Aung Aung Kywe MoeDepartment of Medical Imaging and Radiation Sciences, Monash University, Clayton, Victoria, Australia.
Isaac N EdwardsSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
Helle Bielefeldt-OhmannSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
Katina D HulmeSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
Ellesandra C NoyeSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
Marcus Z W TongSchool of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia Queensland, Australia.
Patrick C ReadingThe Peter Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology, University of Melbourne, Melbourne, Victoria, Australia.
Matthew W TrewellaDepartment of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia.
Stuart B MazzoneDepartment of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia.
Alice E McGovernDepartment of Anatomy and Physiology, The University of Melbourne, Parkville, Victoria, Australia.ORCID 0000-0003-3906-8611
The University of Queensland · AUThe University of Melbourne · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza A virus (IAV) is a common respiratory pathogen and a global cause of significant and often severe morbidity. Although inflammatory immune responses to IAV infections are well described, little is known about how neuroimmune processes contribute to IAV pathogenesis. In the present study, we employed surgical, genetic, and pharmacological approaches to manipulate pulmonary vagal sensory neuron innervation and activity in the lungs to explore potential crosstalk between pulmonary sensory neurons and immune processes. Intranasal inoculation of mice with H1N1 strains of IAV resulted in stereotypical antiviral lung inflammation and tissue pathology, changes in breathing, loss of body weight and other clinical signs of severe IAV disease. Unilateral cervical vagotomy and genetic ablation of pulmonary vagal sensory neurons had a moderate effect on the pulmonary inflammation induced by IAV infection, but significantly worsened clinical disease presentation. Inhibition of pulmonary vagal sensory neuron activity via inhalation of the charged sodium channel blocker, QX-314, resulted in a moderate decrease in lung pathology, but again this was accompanied by a paradoxical worsening of clinical signs. Notably, vagal sensory ganglia neuroinflammation was induced by IAV infection and this was significantly potentiated by QX-314 administration. This vagal ganglia hyperinflammation was characterized by alterations in IAV-induced host defense gene expression, increased neuropeptide gene and protein expression, and an increase in the number of inflammatory cells present within the ganglia. These data suggest that pulmonary vagal sensory neurons play a role in the regulation of the inflammatory process during IAV infection and suggest that vagal neuroinflammation may be an important contributor to IAV pathogenesis and clinical presentation. Targeting these pathways could offer therapeutic opportunities to treat IAV-induced morbidity and mortality.

Indexed as

Influenza A Virus, H1N1 SubtypeOrthomyxoviridae InfectionsSensory Receptor CellsVagus NerveAnimalsFemaleInfluenza, HumanLungMaleMiceMice, Inbred C57BL

Identifiers

PMID38626267
PMCPMC11051609
OpenAlexW4394841146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.